CDNA
CareDx, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$67.08
+4.81%Forward multiples
Based on analyst estimates
- P/E forward
- 58.20x
- P/E 2026E
- 56.04x
- P/E 2027E
- 52.03x
- P/E 2028E
- 36.48x
- P/S forward
- 6.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- 31.17x
- PEG TTM
- —
- Price / book
- 8.15x
- Price / sales
- 7.58x
- Price / cash flow
- 37.05x
Enterprise value
- Enterprise value
- $3.1B
- EV / sales
- 6.80x
- EV / EBITDA
- 200.28x
- EV / EBIT
- -736.46x
- Market cap
- $3.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026